Journal article

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

Sherene Loi, Sandra Pommey, Benjamin Haibe-Kains, Paul A Beavis, Phillip K Darcy, Mark J Smyth, John Stagg

Proceedings of the National Academy of Sciences of the United States of America | NATL ACAD SCIENCES | Published : 2013

Grants

Awarded by Susan G. Komen for the Cure


Awarded by National Health and Medical Research Council of Australia


Awarded by Victorian Cancer Agency


Awarded by National Health and Medical Research Council Australia Fellowship


Funding Acknowledgements

The authors thank Kathleen Spring, Bruno G. Leclerc, Isabelle Cousineau, Martin Turcotte, David Allard, Guillaume Chouinard, Francis Rodier, Guillaume Cardin, Nicole McLaughlin, Qerime Mundrea, and Ben Venville for technical support. This work was supported in part by Susan G. Komen for the Cure (IIR12221504); the National Health and Medical Research Council of Australia (1013667, 1007902); the Victorian Cancer Agency (EOI09_71); the Canadian Institutes of Health Research; the Cancer Research Society of Canada; a National Health and Medical Research Council early career Fellowship and Fonds J. C. Heuson (to S.L.); a National Health and Medical Research Council Career Development Award 2 award (to P.K.D.); National Health and Medical Research Council Australia Fellowship 628623 (to M.J.S.); and the Famille Jean-Guy Sabourin Research Chair of University of Montreal (J.S.).